Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors

Clinical trial NCT05701709 · RECRUITING

Trial details

NCT number: NCT05701709
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-04-06
Primary completion: 2025-08-31
Enrollment: 395

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.